NCT05330858View on ClinicalTrials.gov

Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

March 17, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

September 20, 2022

Conditions

Pharmacokinetics

Interventions

DRUG

ESK-001

Oral tablet or liquid

DRUG

Rabeprazole

Oral Tablet

Trial Locations (1)

91206

Alumis Central Site, Glendale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alumis Inc

INDUSTRY